New trends for anemia at the beginning of a new century

Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander? Arch Intern Med. 2003;163(12):1400-4.

Batista Filho M, Rissin A. A transição nutricional no Brasil: tendências regionais e temporais. [Nutritional transition in Brazil: geographic and temporal trends]. Cad Saúde Pública. 2003;19(Suppl 1):S181-S191.

Levy-Costa RB. Consumo de leite de vaca e anemia na infância no município de São Paulo [dissertation]. São Paulo: Faculdade de Saúde Pública da Universidade de São Paulo; 2002.

Santos LMP. Bibliografia sobre deficiência de micronutrientes no Brasil, 1990-2000: Anemia. Brasília: Organização Pan-Americana da Saúde /Organização Mundial da Saúde; 2002. Available from URL: http://www.opas.org.br/sistema/arquivos/pes_vol2a.pdf. Ac- cessed in 2004 (Aug 17).

Sheth TN, Choudhry NK, Bowes M, Detsky AS. The relation of conjunctival pallor to the presence of anemia. J Gen Intern Med. 1997;12(2):102-6.

Kalter HD, Burnham G, Kolstad PR, et al. Evaluation of clinical signs to diagnose anaemia in Uganda and Bangladesh, in areas with and without malaria. Bull World Health Organ. 1997;75(Suppl 1):103-11.

Sanchez-Carrillo CI. Bias due to conjunctiva hue and the clinical assessment of anemia. J Clin Epidemiol. 1989;42(8):751-4.

Spinelli MGN, Souza JMP, Souza SB, Sesoko EH. Confiabilidade e validade da palidez palmar e de conjuntivas como triagem de anemia. [Reliability and validity of palmar and conjunctival pallor for anemia detection purposes]. Rev Saúde Pública. 2003;37(4):404-8.

Lewis SM, Stott GJ, Wynn KJ. An inexpensive and reliable new haemoglobin colour scale for assessing anaemia. J Clin Pathol. 1998;51(1):21-4.

Drager LF, Abe JM, Martins MA, Lotufo PA, Bensenor IJ. Impact of clinical experience on quantification of clinical signs at physical examination. J Intern Med. 2003;254(3):257-63.

Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol.2003;41(11):1933-9.

Collins AJ, Li S, St Peter W, et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol. 2001;12(11):2465-73.

Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034):1055-60.

Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584-90.

Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34(1):125-34.

Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis. 1999;33(6):1122-30.

Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37(7):1775-80.

Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol. 1995;13(8):2077-83.

Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997;15(3):1218-34.

Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16(10):3412-25.